Please review the required information below (use scroll bar on the right) and then click the
"Access Activity"
button to access this activity.
INTRODUCTION
In this on-demand video presentation, Dr. Stephen Mathai discusses the latest recommendations and methodologies to screen for, detect, and accurately diagnose pulmonary hypertension due to interstitial lung disease (PH-ILD). This case-based presentation addresses the knowledge and competence deficits among healthcare professionals regarding the diagnosis and treatment of PH-ILD.
Launch Date: August 15, 2023
Release Date: August 15, 2023
Expiration Date: July 31, 2024
TARGET AUDIENCE
Clinical Viewpoints PH-ILD activities are designed for healthcare providers who are involved in the clinical care of patients with PH-ILD. This may include physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.
LEARNING OBJECTIVES
Upon completion of this enduring material, participants should be able to:
METHOD OF PARTICIPATION / HOW TO RECEIVE CREDIT
- There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives and CME/CE information.
- Review all modules associated with this course.
- Successfully complete the post-test ( accuracy).
- Complete the CME/CE evaluation.
- The estimated time to complete this activity is hour.
- Upon successful completion, your AMA/ANCC certificate will be emailed to you. ACPE credit will be submitted to Rush University Medical Center and posted to CPE Monitor.
ACCREDITATION STATEMENTS
PHYSICIANS
In support of improving patient care, Rush University Medical Center is jointly accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Rush University Medical Center designates this live activity for a maximum of AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 CreditTM into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).
ANCC Credit Designation – Nurses
Rush University Medical Center designates this enduring material for a maximum of nursing contact hour(s).
PHARMACISTS
Rush University Medical Center designates this knowledge-based enduring material for a maximum of contact hour(s) for pharmacists.
Participation in the entire knowledge-based activity is required to obtain a certificate. This activity is being presented without bias and with commercial support.
RESOLUTION OF CONFLICT OF INTEREST
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is
advised that information presented in this continuing medical education activity may contain references
to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert
for each drug/device for full prescribing/utilization information.
It is the policy of the Rush University Center for Innovative and Lifelong Learning to ensure that its CE
activities are independent, free of commercial bias and beyond the control of persons or organizations
with an economic interest in influencing the content of CE. All individuals who have the ability to
control or influence the content of an educational activity must disclose information about all of their
financial relationships with ineligible companies within the prior 24 months. There is no minimum
financial threshold; individuals must disclose all financial relationships, regardless of the amount, with
ineligible companies. Individuals must disclose regardless of their view of the relevance of the
relationship to the education. Those who must disclose include (but are not limited to) members of the
Planning Committee, speakers, presenters, authors, and/or content reviewers. All information disclosed
must be mitigated and then shared with the participants/learners prior to the start of the educational
activity.
FACULTY AND PLANNING COMMITTEE DISCLOSURES
The following speakers and/or planners have stated that they have the following financial relationship(s) and they have agreed to see that all information they planned and/or present is done so fairly and without bias:
PLANNING COMMITTEE DISCLOSURES
Bronwyn Boyes
Independent Contractor: Novartis Pharmaceuticals
Nothing to Disclose:
Sally Lempke, DNP, WHNP-BC
Jennifer Comerford
Mark Yoder, MD, MS
Colleen Goodchild
FACULTY DISCLOSURES
Stephen Mathai, MD, MHS
Advisory Committee/Board: Aerovate, Janssen, Merck, United Therapeutics
Consultant: Merck
DISCLAIMER
The Rush University Medical Center and Practice Point Communications present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The Rush University Medical Center and Practice Point Communications assume no liability for the information herein.
PRIVACY POLICY
The Rush University Medical Center and Practice Point Communications protect the privacy of personal and other information regarding participants and educational collaborators. The Rush University Medical Center and Practice Point Communications will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME, ANCC, or ACPE.
Rush University Medical Center and Practice Point Communications maintain physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information that we have collected from you.
COPYRIGHT INFORMATION
Any unauthorized use of any materials on the site may violate copyright, trademark, and other laws. You may view, copy, and download information or software (“Materials”) found on the site subject to the following terms, conditions, and exceptions:
The Materials are to be used solely for personal, noncommercial, informational, and educational purposes. The materials are not to be modified. They are to be distributed in the format provided with the source clearly identified. The copyright information or other proprietary notices may not be removed, changed, or altered.
Materials may not be published, uploaded, posted, or transmitted (other than as set forth herein) without prior written permission.
HARDWARE/SOFTWARE REQUIREMENTS
Computer:
- Hardware: A minimum of 512MB of RAM and a Pentium IV CPU for Intel-based hardware & PowerPC G4 or above for MAC.
- Graphics/Monitor: A color monitor capable of a minimum of 1024 x 768 pixel resolution.
- Network: An Internet connection with 1Mbps available download & 256kbps bandwidth.
Software/Browser:
- Windows 7 or above running Internet Explorer 10 or above.
- MAC OSX 10.5 (Leopard) or above running Safari 6 or above, or any version of Chrome, Firefox or Opera published in the last two years.
- A recent version of a Linux distribution or FreeBSD running Chrome v13, Opera 11.5, Firefox 5.0.1, or Epiphany 3.0.4 or above.
Mobile Device:
- Any Apple iPad or iPad Mini running iOS 7.1 or above.
- Android tablets such as the Kindle Fire or Samsung Galaxy S.
COMMERCIAL SUPPORT ACKNOWLEDGMENT
Supported by an independent educational grant from United Therapeutics, a public benefit company